Home/Filings/4/0001062993-23-000719
4//SEC Filing

Gwydir Tom 4

Accession 0001062993-23-000719

CIK 0001196298other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:31 PM ET

Size

11.9 KB

Accession

0001062993-23-000719

Insider Transaction Report

Form 4
Period: 2023-01-05
Gwydir Tom
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-05+7,0807,080 total
    Exercise: $1.07Exp: 2023-01-05Common Stock (7,080 underlying)
  • Award

    Common Stock

    2023-01-05+27,61343,226 total
Holdings
  • Stock Option (right to buy)

    Exercise: $5.31Exp: 2029-04-29Common Stock (9,627 underlying)
    9,627
  • Stock Option (right to buy)

    Exercise: $8.06Exp: 2031-01-06Common Stock
    6,850
  • Stock Option (right to buy)

    Exercise: $6.82Exp: 2031-12-14Common Stock (7,062 underlying)
    7,062
  • Stock Option (right to buy)

    Exercise: $8.57Exp: 2029-12-16Common Stock
    5,568
Footnotes (4)
  • [F1]Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date.
  • [F2]Fully exercisable.
  • [F3]This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.
  • [F4]Represents options granted to the reporting person for his service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001775308

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:31 PM ET
Size
11.9 KB